MDM2 and central nervous system cancer: Research by Xiao Y et al. showed that AMG232 inhibits glioma angiogenesis by blocking the p53-Mdm2 interaction in the p53-RBM4-VEGFR2 pathway, thereby suppressing glioma endothelial cell proliferation [69].